Dual‐Targeted Protein MRI Contrast Agent for Early Detection of Micrometastases
ABSTRACT Tumor metastasis accounts for the major portion of cancer‐related deaths. Magnetic resonance imaging (MRI) is a valuable imaging modality for tumor diagnosis in clinical applications, offering detailed soft tissue images with excellent spatial resolution and good biosafety. However, the low...
Saved in:
| Main Authors: | Ruofan Hu, Zhiyang Wang, Tinghui Shen, Qianwen Yang, Weizhi Chen, Xiqun Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | Aggregate |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/agt2.732 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current approaches to development of contrast agents for MRI diagnostics
by: K. N. Sorokina, et al.
Published: (2011-12-01) -
Advancing neuroimaging: novel manganese- and iron-based MRI contrast agents for cerebral ischemic diseases
by: Xiaojuan Deng, et al.
Published: (2025-08-01) -
The Effectiveness of Calcium Supplement as Orally Contrast Media for Gastric Magnetic Resonance Imaging
by: Zainab Abdulla Mankhi, et al.
Published: (2024-10-01) -
MRI with Contrast Enhancement in a Patient with Chronic Kidney Disease: to Contrast Have Not Be Denied. Where Should We Put the Comma?
by: E. S. Kamyshova, et al.
Published: (2019-03-01) -
A preclinical study of a novel dual-modality contrast agent in rodent models
by: Xuelai Zhou, et al.
Published: (2025-03-01)